Name: TEVA Shares Authorized 2008-2026
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#dissemination

TEVA PHARMACEUTICAL INDUSTRIES LIMITED Shares Authorized

TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) had Shares Authorized of 2.50 billion shares as of 2026-06-30, per its 10-Q filed 2026-07-29.

Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure

us-gaap:CommonStockSharesAuthorized · last filed 2026-07-29

2026-06-30: Common Stock, Shares Authorized 2.50B shares.
2026-03-31: Common Stock, Shares Authorized 2.50B shares.
2025-12-31: Common Stock, Shares Authorized 2.50B shares.
2025-09-30: Common Stock, Shares Authorized 2.50B shares.

Period end	Common Stock, Shares Authorized
2026-06-30	2.50B shares 10-Q · filed 2026-07-29
2026-03-31	2.50B shares 10-Q · filed 2026-04-29
2025-12-31	2.50B shares 10-Q · filed 2026-07-29
2025-09-30	2.50B shares 10-Q · filed 2025-11-05
2025-06-30	2.50B shares 10-Q · filed 2025-07-30
2025-03-31	2.50B shares 10-Q · filed 2025-05-07
2024-12-31	2.50B shares 10-K · filed 2026-02-03
2024-09-30	2.50B shares 10-Q · filed 2024-11-06
2024-06-30	2.50B shares 10-Q · filed 2024-07-31
2024-03-31	2.50B shares 10-Q · filed 2024-05-08
2023-12-31	2.50B shares 10-K · filed 2025-02-05
2023-09-30	2.50B shares 10-Q · filed 2023-11-09
2023-06-30	2.50B shares 10-Q · filed 2023-08-02
2023-03-31	2.50B shares 10-Q · filed 2023-05-10
2022-12-31	2.50B shares 10-K · filed 2024-02-12
2022-09-30	2.50B shares 10-Q · filed 2022-11-03
2022-06-30	2.50K shares 10-Q · filed 2022-07-27
2022-03-31	2.50B shares 10-Q · filed 2022-05-03
2021-12-31	2.50B shares 10-K · filed 2023-02-10
2021-09-30	2.50B shares 10-Q · filed 2021-10-27
2021-06-30	2.50B shares 10-Q · filed 2021-07-28
2021-03-31	2.50B shares 10-Q · filed 2021-04-28
2020-12-31	2.50B shares 10-K · filed 2022-02-09
2020-09-30	2.50B shares 10-Q · filed 2020-11-05
2020-06-30	2.50B shares 10-Q · filed 2020-08-05
2020-03-31	2.50B shares 10-Q · filed 2020-05-07
2019-12-31	2.50B shares 10-K · filed 2021-02-10
2019-09-30	2.50B shares 10-Q · filed 2019-11-07
2019-06-30	2.50B shares 10-Q · filed 2019-08-07
2019-03-31	2.50B shares 10-Q · filed 2019-05-02
2018-12-31	2.50B shares 10-K · filed 2020-02-21
2018-09-30	2.50B shares 10-Q · filed 2018-11-01
2018-06-30	2.50B shares 10-Q · filed 2018-08-02
2018-03-31	2.50B shares 10-Q · filed 2018-05-03
2017-12-31	2.50B shares 10-K · filed 2019-02-19
2016-12-31	2.50B shares 20-F · filed 2017-02-15
2016-09-30	2.50B shares 6-K · filed 2016-11-15
2016-06-30	2.50B shares 6-K · filed 2016-08-04
2016-03-31	2.50B shares 6-K · filed 2016-05-09
2015-12-31	2.50B shares 20-F · filed 2017-02-15
2015-09-30	2.50B shares 6-K · filed 2015-10-29
2015-06-30	2.50B shares 6-K · filed 2015-07-30
2015-03-31	2.50B shares 6-K · filed 2015-04-30
2014-12-31	2.50B shares 20-F · filed 2016-02-11
2014-09-30	2.50B shares 6-K · filed 2014-10-30
2014-06-30	2.50B shares 6-K · filed 2014-07-31
2014-03-31	2.50B shares 6-K · filed 2014-05-02
2013-12-31	2.50B shares 6-K · filed 2014-10-30
2013-09-30	2.50B shares 6-K · filed 2013-10-31
2013-06-30	2.50B shares 6-K · filed 2013-08-01
2013-03-31	2.50B shares 6-K · filed 2013-05-02
2012-12-31	2.50B shares 6-K · filed 2013-10-31
2012-09-30	2.50B shares 6-K · filed 2012-11-01
2012-06-30	2.50B shares 6-K · filed 2012-08-02
2012-03-31	2.50B shares 6-K · filed 2012-05-09
2011-12-31	2.50B shares 6-K · filed 2012-11-01
2011-09-30	2.50B shares 6-K · filed 2011-11-02
2011-06-30	2.50B shares 6-K · filed 2011-07-28
2011-03-31	2.50B shares 6-K · filed 2011-05-11
2010-12-31	2.50B shares 6-K · filed 2011-11-02
2010-09-30	2.50B shares 6-K · filed 2010-11-02
2010-06-30	2.50B shares 6-K · filed 2010-07-27
2010-03-31	1.50B shares 6-K · filed 2010-05-04
2009-12-31	1.50B shares 20-F · filed 2011-02-15
2009-09-30	1.50B shares 6-K · filed 2009-11-03
2009-06-30	1.50B shares 6-K · filed 2009-07-29
2009-03-31	1.50B shares 6-K · filed 2009-05-07
2008-12-31	1.50B shares 20-F · filed 2010-02-22